Expanding blood cancer care and research to Brooklyn and Queens
Official title: Expansion of NCI-sponsored clinical research in hematologic malignancies to Brooklyn and Queens
Funded at New York University School of Medicine · NIH-11471239 · Data updated 2026-11-12
Aimed at bringing more blood cancer care and clinical trials to Brooklyn and Queens to help a diverse patient community.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 1, 2025 |
| Project end | November 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $1,006,598 |
| NIH project number | 7R50CA305218-02 |
| Project ID | NIH-11471239 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with hematologic malignancies in Brooklyn and Queens who seek access to clinical trials and advanced care.
✕Less likely to help
Patients not eligible for ongoing trials or without access to participating centers may see limited direct benefit.
What this research studies
This grant expands access to hematologic cancer trials and care across a large, diverse population in New York City. It supports the Perlmutter Cancer Center in offering more NCI-sponsored trials and community outreach in Brooklyn and Queens. Dr. Peter Martin leads care for lymphoma patients and collaborates with national trial networks to advance research and education in the community. The project prioritizes reducing cancer disparities by improving access, awareness, and participation in cutting-edge treatments. The long-term goal is to translate clinical trial findings into better outcomes for patients in these neighborhoods.
Why it matters
Potential benefit: If successful, more patients in Brooklyn and Queens could access high-quality trials and experimental therapies.
How similar studies have gone: Previous expansion efforts have increased trial enrollment and access in underserved urban communities.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Martin, Peter — New York University School of Medicine
- Study coordinator: Martin, Peter
Related research
Other NIH-funded projects on the same topics.
-
Adapting flow cytometry to detect childhood leukemias in Kenya using a single-test screen
A low-cost, blood-based flow cytometry screen in Kenya aims to detect and triage suspected leukemias in children and young adults.
-
Understanding why patients with blood cancers start and stick with oral cancer medicines
A study to learn what helps or hinders Black patients with blood cancers in starting and continuing their prescribed oral cancer medicines.
-
Why some blood cancer cells survive after treatment by resisting natural killer cells
This work is trying to understand why leftover blood cancer cells in leukemia and multiple myeloma survive treatment by escaping natural killer immune cells.
-
Adapting flow cytometry to detect blood cancers in Kenyan children and young people
A nationwide Kenyan effort will test a cheaper, single-blood-sample screening method using flow cytometry to screen for leukemia in kids and young adults who may have the disease.
-
Next-gen genetic engineering of CD45 to boost CAR-T therapy for blood cancers
A research team is developing a way to make CAR-T cells work for many blood cancers by re-engineering a common blood cell protein called CD45.
-
Single-tube blood test to detect acute blood cancers in Kenyan children and young adults
A simple, low-cost blood test aims to find leukemia early in Kenyan children and young adults so fewer people need painful bone marrow procedures and long travel.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.